Internal Medicine, Endocrinology, Diabetes, & Metabolism · Manassas, VA
NPI
1780847111
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
9001 Digges Rd Ste 101
Manassas, VA, 20110
Phone (571) 363-3082
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
2,573 services
Medicare patients, 2024
463
Average age 74
Drug cost, 2024
$3.0M
4,856 prescriptions
Company payments, 2025
$1,468
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alejandro Santos Leal was code 99214 (office e&m - established), 743 times for 329 patients. In total Alejandro Santos Leal billed 2,573 services in 28 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 743 | 329 | $88.29 | $66K |
| 95251 Test - Miscellaneous | Office | 306 | 129 | $25.30 | $7,742 |
| 99213 Office E&M - Established | Office | 187 | 130 | $63.75 | $12K |
| 99205 Office E&M - New | Office | 71 | 71 | $159.63 | $11K |
| 99204 Office E&M - New | Office | 36 | 36 | $121.27 | $4,366 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 21 | 21 | $12.74 | $268 |
| 99231 Hospital E&M - Subsequent | Facility | 13 | 12 | $41.65 | $541 |
By year: 2022 $90K for 1,081 services; 2023 $99K for 1,527 services; 2024 $124K for 2,573 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alejandro Santos Leal prescribed most often to Medicare patients was Levothyroxine Sodium, with 299 prescriptions and refills. In total Alejandro Santos Leal wrote 4,856 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 299 | 864 | 81 | $3,570 |
| Glimepiride Generic | 217 | 608 | 72 | $1,339 |
| Ozempic Semaglutide | 187 | 382 | 54 | $374K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 186 | 448 | 62 | $441K |
| Pioglitazone Hcl Generic | 184 | 506 | 56 | $2,458 |
| Trulicity Dulaglutide | 180 | 318 | 48 | $311K |
| Atorvastatin Calcium Generic | 167 | 482 | 62 | $1,598 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 149 | 364 | 41 | $210K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 146 | 412 | 68 | $18K |
| Rosuvastatin Calcium Generic | 136 | 371 | 42 | $2,547 |
| Metformin Hcl Generic | 134 | 388 | 43 | $937 |
| Mounjaro Tirzepatide | 132 | 203 | 30 | $216K |
| Jardiance Empagliflozin | 123 | 263 | 31 | $156K |
| Metformin Hcl Er Metformin Hcl | 107 | 298 | 35 | $779 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 105 | 216 | 26 | $146K |
Brand drugs: 2,166 claims; generic drugs: 2,358 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alejandro Santos Leal $1,468 ($1,468 in general payments such as food, travel and fees) from 22 companies. The largest payer was Lilly USA, LLC with $185.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 8 | $185 |
| Amgen Inc. AMGN | 8 | $135 |
| Beta Bionics, Inc. BBNX | 5 | $117 |
| Abbvie Inc. ABBV | 5 | $114 |
| Novo Nordisk Inc NVO | 5 | $98.3 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $92.38 |
| IBSA Pharma Inc. | 4 | $87.72 |
| Madrigal Pharmaceuticals MDGL | 4 | $83.92 |
| Mannkind Corporation MNKD | 3 | $82.9 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $70.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.